HKU Scholars Hub: Browsing DSpace

Browsing by Author Ong, CK

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 9 of 9

	Title	Author(s)	Issue Date	Views
	ALK-Negative Anaplastic Large Cell Lymphomas Encompass Distinct Subgroups Including an ALK-Positive-like Subgroup with Favorable Prognosis Proceeding/Conference:Blood	Au Yeung, KHR Russel, V Choi, WL Wong, A Tsui, L Lee, YYC Li, J Singh, GHH Ip, HW Kwong, YL Dave, T Ondrejka, SL Bhagat, G Chadburn, A Rutherford, SC Koff, JL Jaye, DL Czader, M Louissaint, A Li, S Xu, J Yin, CC Ong, CK Cheng, CL Behdad, A Evens, AM Norgaard, PH Gang, AO Leppa, S Karjalainen-Lindsberg, ML Chapman, JR Amador, C Iqbal, J Fedoriw, Y Bogusz, AM Evans, AG Juskevicius, R Hsi, ED Naresh, KN Dave, SS Tse, EWC	2021	30
	Buddhist Counseling: Implications for Mental Health Professionals Journal:Spirituality in Clinical Practice	Lee, KC Oh, A Zhao, Q Wu, FY Chen, S Diaz, T Ong, CK	2017	58
	Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS Journal:Haematologica	Wai, CMM Chen, S Phyu, T Fan, S Leong, SM Zheng, W Low, LCY Choo, SN Lee, CK Chung, TH Ban, KHK Ghosh, S Lie, S Kato, S Nakamura, S Takahashi, E Ko, YH Khoury, JD Chuang, SS Au Yeung, KHR Tan, SY Lim, ST Ong, CK Ho, YH Poon, LM De Mel, S Jeyasekharan, AD Chng, WJ Otto, F Quintanilla-Martinez, L Zanardi, F Iannelli, F Tripodo, C Pitt, JJ Ng, SB	2022
	Phase 3 study of first-line crizotinib vs pemetrexed−cisplatin/carboplatin in East Asian patients with ALK+ advanced non-squamous non-small cell lung cancer (NSCLC) Proceeding/Conference:Journal of Clinical Oncology	Lu, S Mok, T Lu, Y Zhou, Y Shi, YK Sriuranpong, V Ho, JCM Ong, CK Tsai, CM Chung, CH Wilner, KD Tang, Y Masters, E Selaru, P Wu, YL	2016	294
	Repentance in Chinese Buddhism: Implications for mental health professionals Journal:Journal of Spirituality in Mental Health	Lee, KCG Oh, A Zhao, Q Wu, FY Chen, S Diaz, T Ong, CK	2017	94
	Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non–Small Cell Lung Cancer Journal:Journal of Thoracic Oncology	Wu, YL Lu, S Lu, Y Zhou, JY Shui, YK Sriuranpong, V Ho, JCM Ong, CK Tsai, CM Chung, CH Wilner, KD Tang, Y Masters, ET Selaru, P Mok, TS	2018	60
	T-Cell Lymphoma Clonality by Copy Number Variation Analysis of T-Cell Receptor Genes Journal:Cancers	Oon, ML Lim, JQ Lee, B Leong, SM Soon, GST Wong, ZW Lim, EH Li, Z Yeoh, AEJ Chen, S Ban, KHK Chung, TH Tan, SY Chuang, SS Kato, S Nakamura, S Takahashi, E Ho, YH Khoury, JD Au Yeung, RKH Cheng, CL Lim, ST Chng, WJ Tripodo, C Rotzchke, O Ong, CK Ng, SB	2021	14
	The Satipaṭṭhāna Sutta: an Application of Buddhist Mindfulness for Counsellors Journal:Contemporary Buddhism	Lee, KCG Ong, CK	2018	72
	Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma Journal:Leukemia	Lim, JQ Huang, D Tang, T Tan, D Laurensia, Y Peng, RJ Wong, EKY Cheah, DMZ Chia, BKH Iqbal, J Grigoropoulos, NF Nairismägi, ML Ng, CCY Rajasegaran, V Hong, H Kim, SJ Cho, J Tse, E Mow, B Cai, QC Poon, LM Cai, QQ Tan, J Chan, JY Lim, JX Goh, YT Phipps, C Rötzschke, O Cheng, CL Ha, JCH Khoo, LP Loh, YSM Au Yeung, R Chan, TSY Kwong, YL Hwang, W Kim, WS Bei, JX Lin, T Ong, CK Lim, ST	2020	48

Showing results 1 to 9 of 9